Spinal Modulation, a company that makes treatments for chronic spinal pain, has brought in $27.4 million in a third round of capital to finance trials of its lead medical device. Based in Menlo Park, Calif., the company is backed by Johnson & Johnson Development Corp., InCube Ventures, Raffle Venture Partners, DeNovo... (Read more)
Reprinted with permission from VentureBeat. Story copyright 2009 VentureBeat Inc. All rights reserved.






Post new comment